When worlds collide: Th17 and Treg cells in cancer and 133 autoimmunity, Cell. Mol. Immunol, vol.15, pp.458-469, 2018. ,
FOXP3+ regulatory T cells 135 in the human immune system, Nat. Rev. Immunol, vol.10, pp.490-500, 2010. ,
The regulation of immune tolerance by FOXP3, Nat. Rev ,
, , vol.17, pp.703-717, 2017.
Next-generation regulatory T 139 cell therapy, Nat. Rev. Drug Discov, vol.18, pp.749-769, 2019. ,
Human FOXP3+ regulatory T cell heterogeneity 141 and function in autoimmunity and cancer, Immunity, vol.50, pp.302-316, 2019. ,
Development and maintenance of regulatory T 143 cells, Immunity, vol.38, pp.414-423, 2013. ,
Metabolic control of T-cell immunity via epigenetic 145 mechanisms, Cell. Mol. Immunol, vol.15, pp.203-205, 2018. ,
Global mapping of H3K4me3 and H3K27me3 reveals specificity and 147 plasticity in lineage fate determination of differentiating CD4+ T cells, Immunity, vol.30, pp.155-148, 2009. ,
Treg cells require the phosphatase PTEN to restrain TH1 and TFH cell 150 responses, Nat. Immunol, vol.16, pp.178-187, 2015. ,
Mitochondrial complex III is essential for suppressive function of 152 regulatory T cells, Nature, vol.565, pp.495-499, 2019. ,
Regulatory T cells under the mercy of mitochondria, Cell, vol.154, pp.243-245, 2019. ,
URL : https://hal.archives-ouvertes.fr/inserm-02455433
Absence of signaling into 156 CD4+ cells via C3aR and C5aR enables autoinductive TGF-?1 signaling and induction of 157 Foxp3+ regulatory T cells, Nat. Immunol, vol.14, pp.162-171, 2013. ,
Metabolic control of TH17 and induced Treg cell balance by an epigenetic 159 mechanism, Nature, vol.548, pp.228-233, 2017. ,
Conversion of antigen-specific effector/memory T cells into Foxp3-161 expressing Treg cells by inhibition of CDK8/19, Sci. Immunol, vol.4, p.2707, 2019. ,
Molecular and in vivo functions of 163 the CDK8 and CDK19 kinase modules. Front, Cell Dev. Biol, vol.6, p.171, 2018. ,
Inhibitors of cyclin-165 dependent kinases as cancer therapeutics, Pharmacol. Ther, vol.173, pp.83-105, 2017. ,
CDK8/19 Mediator kinases potentiate induction of transcription by 167 ,
, NF?B. Proc. Natl. Acad. Sci. USA, vol.114, pp.10208-10213, 2017.
Regulatory T cells in the treatment of disease, Nat. Rev. Drug Discov, vol.169, pp.823-844, 2018. ,
URL : https://hal.archives-ouvertes.fr/hal-01914953
Past, present, and 171 future of regulatory T cell therapy in transplantation and autoimmunity, Front. Immunol, vol.172, p.43, 2019. ,
Revisiting IL-2: 174 biology and therapeutic prospects, Sci. Immunol, vol.3, p.1482, 2018. ,
Assessing the mechanism and therapeutic potential of modulators of 176 the human Mediator complex-associated protein kinases, Elife, vol.5, p.20722, 2016. ,
Tregs: where we are and what comes next? Front ,
, Immunol, vol.8, p.1578, 2017.
Regulatory T cells induce activation rather than suppression of human 180 basophils, Sci. Immunol, vol.3, p.829, 2018. ,
, -methyl-1H-190 benzimidazol-5-yl)-1H-imidazo[4,5-c]pyridin-2-yl]-1,2,5-oxadiazol-3-amine dihydrochloride) 191 converts the antigen-specific effector/memory T cells into Foxp3+ regulatory T cells, contrast, inhibition of CDK8/19 by AS2863619
AS2863619 keeps the active state of STAT5 (phosphorylation at tyrosine in the ,
, Although not observed under in vitro 197 conditions, in vivo AS2863619-induced Tregs also displayed stable Treg-specific demethylation 198 features at Foxp3 and Helios gene loci. Moreover, AS treatment rendered protective effects in 199 the mouse models of allergy and autoimmune diseases by increasing the Foxp3+ T cells, C-ter) domain), which binds to regulatory regions of the Foxp3 locus majorily at 194